Back to results
US 7,214,367 B2Granted
Orally-administered interferon-tau compositions and methods
AssigneeUniversity of Florida
InventorsJeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
Life of this patent
Estimating the term…
Abstract
The present invention includes interferon-tau (IFNτ) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
Claims5
A method of reducing probability of relapse in a mammal with chronic, relapsing-remitting multiple sclerosis, comprising:
- orally administering an interferon tau (IFNτ) to said mammal in an amount effective to reduce probability of relapse of the chronic relapsing-remitting multiple sclerosis, and continuing to administer the IFNτ over an extended period of time.
Dependencies are inferred from the claim text.